Project/Area Number |
26462416
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Kagoshima University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
関 直彦 千葉大学, 大学院医学研究院, 准教授 (50345013)
|
Co-Investigator(Renkei-kenkyūsha) |
KATAOKA Kazunori 東京大学, 疾患生命工学センター, 教授 (00130245)
MIYATA Kanjiro 東京大学, 疾患生命工学センター, 准教授 (50436523)
|
Research Collaborator |
INOGUCHI Satoru 鹿児島大学, 医歯学総合研究科, 大学院生
ISHIHARA Tomoaki 鹿児島大学, 医歯学総合研究科, 大学院生
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥260,000 (Direct Cost: ¥200,000、Indirect Cost: ¥60,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
|
Keywords | マイクロRNA / 膀胱癌 / microRNA / ナノミセル |
Outline of Final Research Achievements |
Based on the microRNAs expression profile by next generation sequencing in bladder cancer, we identified several tumor suppressive microRNAs including miR-144-5p/3p and miR-23b/24/27b and found their target tumor-associated genes such as c-MET, EGFR involved in important cancer signaling pathway or cyclin E1/E2 involved in cell cycle. MicroRNA-based studies revealed novel cancer biology. We are planning in vivo study following these results.
|